Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
291 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (5%) | |
| Resolved: | 271 (93%) | |
Discontinuation Reports |
61 |
|
| To be discontinued: | 7 (11%) | |
| Discontinued: | 53 (87%) | |
| Reversed: | 1 (2%) | |
Late reports |
21 (6%) |
|
Overdue reports |
5 (45%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-01-25 | 2019-02-27 | 73630 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-04-02 | 2019-05-10 | 80308 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2021-04-09 | 2021-05-04 | 137220 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2022-11-29 | 2022-12-23 | 176325 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-01-17 | 2023-01-30 | 181300 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-05-17 | 2023-06-01 | 192669 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-11-07 | 2024-01-02 | 209520 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2024-05-27 | 2024-06-06 | 228879 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2018-09-26 | 2019-08-12 | 62424 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2022-03-16 | 2022-07-12 | 156783 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2023-07-19 | 2023-07-21 | 199221 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2025-06-16 | 2025-06-24 | 260410 |
| RENAGEL | 800MG | TABLET | Resolved | 2025-04-17 | 2025-08-30 | 255211 |
| RENVELA | 800MG | TABLET | Resolved | 2019-01-04 | 2019-01-10 | 71284 |
| RENVELA | 800MG | TABLET | Resolved | 2024-02-16 | 2024-05-15 | 219863 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Resolved | 2024-07-26 | 2025-04-03 | 233720 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Resolved | 2024-10-22 | 2025-04-03 | 240885 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2019-05-28 | 2019-10-15 | 84937 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2021-02-16 | 2021-05-22 | 134202 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2024-02-23 | 208624 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 800MG | TABLET | Reversed | 2025-03-31 | 2025-09-26 | 253680 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |